Upload
sobha-koduru
View
238
Download
0
Embed Size (px)
Citation preview
8/3/2019 Dka and Honk
http://slidepdf.com/reader/full/dka-and-honk 1/30
Diabetic Ketoacidosis &
Hyperosmolar HyperglycemicState- Inpatient management
Susan Schayes M.D
Assistant Professor-CT
Family Medicine, Emory University
School of Medicine
8/3/2019 Dka and Honk
http://slidepdf.com/reader/full/dka-and-honk 2/30
2
High Impact Diseases
/
Jonas Brothers
8/3/2019 Dka and Honk
http://slidepdf.com/reader/full/dka-and-honk 3/30
3
Learning objectives
• Define diagnostic criteria
for diabetic ketoacidosis
• Define diagnostic criteria
for hyperosmolar
hyperglyemia
• Understand the five keycomponents to the
treatment algorithm
8/3/2019 Dka and Honk
http://slidepdf.com/reader/full/dka-and-honk 4/30
.
In 1552 BC
Diabetes 1st Described In Writing
• Earliest known record of diabetes
mentioned on 3rd Dynasty Eqyptian papyrus
by physician Hesy-Ra: mentions polyuriaas a symptom.
• 250 BC, Apollonius of Memphis coined the
name "diabetes” meaning "to go through"
or siphon. He understood that the disease
drained more fluid than a person could
consume.
8/3/2019 Dka and Honk
http://slidepdf.com/reader/full/dka-and-honk 5/30
.
The Word Diabetes Mellitus
First Used
• Gradually the Latin word for honey,
"mellitus," was added to diabetes because
it made the urine sweet.
• Up to 11th
century diabetes was commonlydiagnosed by “water tasters” who drank the
urine of those suspected of having
diabetes, as it was sweet-tasting.
8/3/2019 Dka and Honk
http://slidepdf.com/reader/full/dka-and-honk 6/30
Early Diabetes Discoveries
• In the 1869, Paul Langerhans, a
German medical student announced
in a dissertation, that the pancreascontains two systems of cells.
•1889 Oskar Minkowski and Josephvon Mering in France, removed the
pancreas from a dog to determine
the effect of an absent pancreas on
digestion
8/3/2019 Dka and Honk
http://slidepdf.com/reader/full/dka-and-honk 7/30
7
Fredrick Banting &
Charles Best
• Boss leaves on vacation
May 1921
• Banting and his assistant
Best isolate insulin fromdogs, and give it to
diabetic dogs.
• Boss returns and is
skeptical that insulin
works
• Try extract on
themselves, then on:
8/3/2019 Dka and Honk
http://slidepdf.com/reader/full/dka-and-honk 8/30
8
Leonard Thompson
The first patient to receive injections of
pancreatic extract on January 11, 1922. He was
14. The young Toronto resident had been
diabetic since 1919. He weighed only 65 poundsand was about to slip into a coma and die. At
first he received Dr, F. Banting’s and Dr. Charles
Best’s extract. Two weeks later he used the
purified extract of Dr. J.B. Collip and
Thompson's symptoms began to disappear; his
blood sugar returned to normal and he was
brighter and stronger. Thompson lived another
13 years with the insulin. He died at the age of
27 due to pneumonia, a complication of his
diabetes
8/3/2019 Dka and Honk
http://slidepdf.com/reader/full/dka-and-honk 9/30
Type 1 vs. type 2 diabetesLambert P, et al. Medicine 2006; 34(2): 47-51
Nolan JJ. Medicine 2006; 34(2): 52-56
Features of type 2 diabetes
• Usually presents in over-30s (butalso seen increasingly inyounger people)
• Associated with
overweight/obesity• Onset is gradual and diagnosis
often missed (up to 50% of cases)
• Not associated with
ketoacidosis, though ketosis canoccur
• Immune markers in only 10%
• Family history is often positivewith almost 100% concordancein identical twins
Features of type 1 diabetes
• Onset inchildhood/adolescence
• Lean body habitus
• Acute onset of osmoticsymptoms
• Ketosis-prone
• High levels of isletautoantibodies
• High prevalence of geneticsusceptibility
8/3/2019 Dka and Honk
http://slidepdf.com/reader/full/dka-and-honk 10/30
Goals of management• Manage symptoms
• Prevent acute and late complications• Improve quality of life
• Avoid premature diabetes-associated death
• An individualized approach
Management
Glycemic
control
BP
Lipids
Patienteducation
Lifestyle
(e.g. diet & exercise)
Foot care
Eye careMicroalbuminuria
& kidneys
8/3/2019 Dka and Honk
http://slidepdf.com/reader/full/dka-and-honk 11/30
11
Normal Physiologic Insulin
Sensitivity and β-Cell Function
Produce Euglycemia
Pancreas
Normal Insulin Sensitivity
Liver
EuglycemiaEuglycemia
Islet β-Cell Degranulation;
Insulin Released in Response to
Elevated Plasma Glucose Muscle Adipose Tissue
Increased Glucose
Transport
Decreased
Lipolysis
↓ Glucose
Production
↑ Glucose
Uptake
Normal Physiologic
Plasma Insulin
Decreased Glucose Output
Normal β-Cell Function
Decreased
Plasma FFA
Decreased
Plasma FFA
8/3/2019 Dka and Honk
http://slidepdf.com/reader/full/dka-and-honk 12/30
12
β-Cell Dysfunction and Insulin
Resistance Produce Hyperglycemia in
Type 2 Diabetes
Pancreas
Insulin Resistance
Liver
HyperglycemiaHyperglycemia
Islet β-Cell Degranulation;
Reduced Insulin Content
Muscle Adipose Tissue
Decreased Glucose
Transport & Activity
(expression)
of GLUT4
Increased
Lipolysis
↑Glucose
Production
↓Glucose
Uptake
Reduced
Plasma Insulin
Increased Glucose Output
β-Cell Dysfunction
Elevated
Plasma FFA
Elevated
Plasma FFA
8/3/2019 Dka and Honk
http://slidepdf.com/reader/full/dka-and-honk 13/30
13
Diabetic Ketoacidosis:
• Key features: hyperglycemia, ketosis, acidosis
• Clinical presentation: polyuria, polydipsia,
polyphagia, weakness, Kussmauls’respirations,
nausea and vomiting
• Can be mistaken for AGE
8/3/2019 Dka and Honk
http://slidepdf.com/reader/full/dka-and-honk 14/30
14
Diabetic Ketoacidosis
•
Cause: reduced insulin levels, decreasedglucose use, increased gluconeogenesis
Primarily affects TIDM, but can be T2DM
Precipitating factor: Infection,
Noncompliance,
Other acute event ie MI
8/3/2019 Dka and Honk
http://slidepdf.com/reader/full/dka-and-honk 15/30
15
Diabetic Ketoacidosis:
• Treatment involves 5 key components:
• Monitoring
• Fluid resuscitation
• Insulin and dextrose infusion
• Electrolyte repletion
• Treating underlying cause
8/3/2019 Dka and Honk
http://slidepdf.com/reader/full/dka-and-honk 16/30
PATHOGENESIS
OsmoticDiuresis
Renal Hypoperfusion
Impaired Excretion of Ketones & Hydrogen ions
Fluid & ElectrolyteDepletion
Vomitin
g
AcidosisHyperglycemia
Glycosuria
GlucoseKetones
Ketoacidosis
is a state of
uncontrolled catabolismassociated with
insulin deficiency.
8/3/2019 Dka and Honk
http://slidepdf.com/reader/full/dka-and-honk 17/30
CLINICAL FEATURES
• Polyuria leading to Oliguria
• Dehydration, Thirst
• Hypotension, Tachycardia,
• Peripheral circulatory failure
• Ketosis
• Hyperventilation
• Vomiting
• Abdominal pain (acute abdomen)
• Drowsiness, Coma
8/3/2019 Dka and Honk
http://slidepdf.com/reader/full/dka-and-honk 18/30
METABOLIC FEATURES
• Hyperglycemia
• Glycosuria
• Non-respiratory Acidosis
• Ketonemia
• Uremia
• Hyperkalemia
• Hypertriglyceridemia
• Hemoconcentration
8/3/2019 Dka and Honk
http://slidepdf.com/reader/full/dka-and-honk 19/30
19
Dx Criteria for Mild DKA
• Glucose > 250
• Arterial pH 7.25-7.30• Serum bicarb 15-18 mEq• Urine and Serum ketones
• B-hydroxybutyrate- high• Anion gap >10• Patient is alert
Trachtenbarg David, Diabetic Ketoacidosis, American Family Physician,2005;71:1705-1714
8/3/2019 Dka and Honk
http://slidepdf.com/reader/full/dka-and-honk 20/30
20
Dx Criteria for Moderate DKA
• Glucose > 250
• Arterial pH 7.00-7.24• Serum bicarb 10 to <15 mEq• Urine and Serum ketones
• B-hydroxybutyrate- high• Anion gap >12• Patient is alert/drowsy
Trachtenbarg David, Diabetic Ketoacidosis, American Family Physician,2005;71:1705-1714
8/3/2019 Dka and Honk
http://slidepdf.com/reader/full/dka-and-honk 21/30
21
Dx Criteria for Severe DKA
• Glucose > 250
• Arterial pH <7.00• Serum bicarb <10 mEq• Urine and Serum ketones
• B-hydroxybutyrate- high• Anion gap >12• Patient is stupor/coma
Trachtenbarg David, Diabetic Ketoacidosis, American Family Physician,2005;71:1705-1714
8/3/2019 Dka and Honk
http://slidepdf.com/reader/full/dka-and-honk 22/30
22
Dx Criteria for HHS
• Glucose > 600
• Arterial pH <7.30• Serum bicarb <15 mEq• Urine and Serum ketones- small
• B-hydroxybutyrate- n or elevated• Anion gap-variable• Patient is stupor/coma
Trachtenbarg David, Diabetic Ketoacidosis, American Family Physician,2005;71:1705-1714
8/3/2019 Dka and Honk
http://slidepdf.com/reader/full/dka-and-honk 23/30
23
DKA- Monitoring
• ICU
• 2 IV’s, Oxygen, cardiac monitor,continuous vitals, pulse ox
• Foley to monitor I &O
• Initially blood work every 1-2 hours
• If pH is less that 6.9 be frightened
8/3/2019 Dka and Honk
http://slidepdf.com/reader/full/dka-and-honk 24/30
24
DKA- Monitoring
Standard blood work
• Glucose, lytes with calculated anion gap, Mag
• Bun & creatinine, calculate GFR
• Beta-hydroxybutyrate or serum ketones• UA
• CBC
• EKG
• Infection-cultures,chest xray
• Cardiac status-cardiac enzymes
8/3/2019 Dka and Honk
http://slidepdf.com/reader/full/dka-and-honk 25/30
25
DKA- Fluids
• Deficits are typically 100 ml per kg
• Fluid replacement will lower glucose• Initial Tx usually fluid, fluid, fluid
• Initial resuscitation 15-20 ml/kg stat for severedehydration with normal saline
• 1l,1l,1l,then 500ml X4 hours, reassess/reassess
• Once glucose below 250, switch to
D5W/.45% N saline
8/3/2019 Dka and Honk
http://slidepdf.com/reader/full/dka-and-honk 26/30
26
Insulin
• Initially 10 units R Insulin IV,
.15 units/kg
• Insulin drip, most protocols 5-7units per hour, .1 units/kg/hr
• Patient to ICU
•Stop insulin drip when sugar isless than 250
8/3/2019 Dka and Honk
http://slidepdf.com/reader/full/dka-and-honk 27/30
27
Electrolytes- K
• Whole body potassium deficits exist. (3-5
mmol/kg)
• Acidosis increases K• Glucose + Insulin lowers K
• Start K with K less than 5 mmol and adequate
urine output
• If initial K less than 3.3 mmol
replete, and then start insulin when K above 3.3
mmol/L
8/3/2019 Dka and Honk
http://slidepdf.com/reader/full/dka-and-honk 28/30
28
Electrolytes- K
• Commonly under repleted
• Resident mistakenly uses the replacement of potassium protocol, which vastly under repletes
potassium
• Watch like a hawk!!!!
• Replace/repete/replace/repete
8/3/2019 Dka and Honk
http://slidepdf.com/reader/full/dka-and-honk 29/30
29
Electrolytes- Mg
• A serum deficit usually exists
of .5-1 mmol per L
• Consider repleting if less than 1.8 mg/dL